Heartfulness meditation trial reports mood and hormone changes
Participants reported changes in mood alongside shifts in blood markers, but the abstract leaves key details of the sample and comparisons unclear.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The trial reported better positive and negative mood scores alongside changes in cortisol, oxytocin, and beta-endorphins after guided Heartfulness meditation. Similar changes were reported when the control group later received meditation. These findings concern questionnaires and blood markers; they do not establish recovery from a mental health condition or lasting stress resilience.
Participant numbers and characteristics are missing. The abstract also omits hormone units and does not clearly identify the group contrasts or assessment times underlying each reported effect.
What the abstract measured
Researchers measured meditation depth and positive and negative affect using questionnaires, alongside serum hormone levels. The abstract describes increased meditation depth and positive affect, reduced negative affect, and changes in all measured hormones.
What hormone changes establish
Cortisol decreased, while oxytocin and beta-endorphins increased. These laboratory results are distinct from clinical mental health outcomes. The later crossover provides another observation during meditation, but the abstract does not establish persistence after practice ended.
The original publication
Heartfulness meditation alters neuroendocrine profiles: A randomized controlled trial on hormones of stress and well-being.
Philip ST, Thimmapuram J, Thakur K et al.
Medicine (Baltimore) · 2025
- PubMed ID
- 41305815
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.